The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions
NCT06228339
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
44
Enrollment
NETWORK
Sponsor class
Conditions
Healthy Volunteer
Interventions
DRUG:
Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets
DRUG:
Xatral® XL 10 mg
Sponsor
International Bio service